Low Expression of ATM Indicates a Poor Prognosis in Clear Cell Renal Cell Carcinoma
- 1 June 2019
- journal article
- research article
- Published by Elsevier in Clinical Genitourinary Cancer
- Vol. 17 (3) , e433-e439
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81572523)
- National Key R&D Program of China (2016YFC0902603)
This publication has 21 references indexed in Scilit:
- Localized chromophobe renal cell carcinoma: preoperative imaging judgment and laparoscopic simple enucleation for treatmentInternational braz j urol, 2018
- Wide spetcrum mutational analysis of metastatic renal cell cancer: a retrospective next generation sequencing approachOncotarget, 2016
- Kinase Gene Expression Profiling of Metastatic Clear Cell Renal Cell Carcinoma Tissue Identifies Potential New Therapeutic TargetsPLOS ONE, 2016
- A prospective risk-stratified follow-up programme for radically treated renal cell carcinoma patients: evaluation after eight years of clinical useWorld Journal of Urology, 2016
- Spectrum of diverse genomic alterations define non–clear cell renal carcinoma subtypesNature Genetics, 2014
- Cancer StatisticsJAMA, 2013
- JAK3 in clear cell renal cell carcinoma: Mutational screening and clinical implicationsUrologic Oncology: Seminars and Original Investigations, 2013
- ATM and the Molecular Pathogenesis of Ataxia TelangiectasiaAnnual Review of Pathology: Mechanisms of Disease, 2012
- p53 and MDM2 in renal cell carcinomaCancer, 2010
- Classification of renal cell carcinomaCancer, 1997